• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Anthropometric metabolic subtypes and health outcomes: A data-driven cluster analysis.人体测量代谢亚型与健康结局:一项数据驱动的聚类分析。
Diabetes Obes Metab. 2025 Jun;27(6):2955-2966. doi: 10.1111/dom.16299. Epub 2025 Feb 28.
2
Associations Between Measures of Sarcopenic Obesity and Risk of Cardiovascular Disease and Mortality: A Cohort Study and Mendelian Randomization Analysis Using the UK Biobank.肌少症性肥胖测量指标与心血管疾病和死亡风险的关联:基于英国生物库的队列研究和孟德尔随机化分析。
J Am Heart Assoc. 2019 Jul 2;8(13):e011638. doi: 10.1161/JAHA.118.011638. Epub 2019 Jun 21.
3
Novel metabolic and inflammatory stratification of overweight/obesity to characterize risks of adverse outcomes: A large population-based cohort study.超重/肥胖的新型代谢与炎症分层以表征不良结局风险:一项基于大规模人群的队列研究。
Diabetes Obes Metab. 2025 May;27(5):2613-2625. doi: 10.1111/dom.16262. Epub 2025 Feb 19.
4
Determining the best method for evaluating obesity and the risk for non-communicable diseases in women of childbearing age by measuring the body mass index, waist circumference, waist-to-hip ratio, waist-to-height ratio, A Body Shape Index, and hip index.探讨通过测量体重指数、腰围、腰臀比、腰围身高比、身体质量指数(A Body Shape Index)和臀围指数来评估育龄妇女肥胖和非传染性疾病风险的最佳方法。
Nutrition. 2023 Oct;114:112135. doi: 10.1016/j.nut.2023.112135. Epub 2023 Jun 16.
5
Anthropometric indicators and cardiovascular diseases risk in pre-diabetic and diabetic adults: NHANES 1999-2018 cross-sectional analysis.在糖尿病前期和糖尿病成人中,人体测量指标与心血管疾病风险:NHANES 1999-2018 横断面分析。
Exp Gerontol. 2024 Sep;194:112516. doi: 10.1016/j.exger.2024.112516. Epub 2024 Jul 10.
6
Independent and joint associations of grip strength and adiposity with all-cause and cardiovascular disease mortality in 403,199 adults: the UK Biobank study.403199名成年人握力和肥胖与全因死亡率及心血管疾病死亡率的独立和联合关联:英国生物银行研究
Am J Clin Nutr. 2017 Sep;106(3):773-782. doi: 10.3945/ajcn.117.156851. Epub 2017 Aug 9.
7
Inflammatory markers link triglyceride-glucose index and obesity indicators with adverse cardiovascular events in patients with hypertension: insights from three cohorts.炎症标志物将高血压患者的甘油三酯-葡萄糖指数和肥胖指标与不良心血管事件联系起来:来自三个队列的见解
Cardiovasc Diabetol. 2025 Jan 8;24(1):11. doi: 10.1186/s12933-024-02571-x.
8
Associations of modified triglyceride-glucose indices and the triglyceride/high-density lipoprotein ratio with all-cause and cause-specific mortality in the general population: an analysis of the UK biobank database.一般人群中改良甘油三酯-葡萄糖指数及甘油三酯/高密度脂蛋白比值与全因死亡率和特定病因死亡率的关联:英国生物银行数据库分析
Lipids Health Dis. 2025 Apr 1;24(1):126. doi: 10.1186/s12944-025-02540-7.
9
Associations of metabolic changes and polygenic risk scores with cardiovascular outcomes and all-cause mortality across BMI categories: a prospective cohort study.代谢变化和多基因风险评分与 BMI 类别相关的心血管结局和全因死亡率的关联:一项前瞻性队列研究。
Cardiovasc Diabetol. 2024 Jul 4;23(1):231. doi: 10.1186/s12933-024-02332-w.
10
Association of walking pace and handgrip strength with all-cause, cardiovascular, and cancer mortality: a UK Biobank observational study.步行速度和握力与全因、心血管和癌症死亡率的关联:一项英国生物银行观察性研究。
Eur Heart J. 2017 Nov 14;38(43):3232-3240. doi: 10.1093/eurheartj/ehx449.

本文引用的文献

1
Subclassification of obesity for precision prediction of cardiometabolic diseases.肥胖的亚分类用于心血管代谢疾病的精准预测。
Nat Med. 2025 Feb;31(2):534-543. doi: 10.1038/s41591-024-03299-7. Epub 2024 Oct 24.
2
Tissue-specific activation of insulin signaling as a potential target for obesity-related metabolic disorders.组织特异性胰岛素信号激活作为肥胖相关代谢紊乱的潜在靶点。
Pharmacol Ther. 2024 Oct;262:108699. doi: 10.1016/j.pharmthera.2024.108699. Epub 2024 Aug 5.
3
Central Lean Mass Distribution and the Risks of All-Cause and Cause-Specific Mortality in 40,283 UK Biobank Participants.40283 名英国生物样本库参与者的中心性 lean 组织分布与全因和特定原因死亡率的风险。
Obes Facts. 2024;17(5):502-512. doi: 10.1159/000540219. Epub 2024 Jul 24.
4
Metabolically healthy obesity: from epidemiology and mechanisms to clinical implications.代谢健康型肥胖:从流行病学、机制到临床意义。
Nat Rev Endocrinol. 2024 Nov;20(11):633-646. doi: 10.1038/s41574-024-01008-5. Epub 2024 Jun 27.
5
Novel subgroups of obesity and their association with outcomes: a data-driven cluster analysis.肥胖的新型亚组及其与结局的关联:基于数据驱动的聚类分析。
BMC Public Health. 2024 Jan 9;24(1):124. doi: 10.1186/s12889-024-17648-1.
6
Association between Sarcopenia and Poor Glycemic Control in Older Adults with Type 2 Diabetes Mellitus.2型糖尿病老年患者肌肉减少症与血糖控制不佳之间的关联。
Diseases. 2023 Nov 30;11(4):175. doi: 10.3390/diseases11040175.
7
Sarcopenic obesity: emerging mechanisms and therapeutic potential.肌少症性肥胖:新兴机制与治疗潜力。
Metabolism. 2023 Sep;146:155639. doi: 10.1016/j.metabol.2023.155639. Epub 2023 Jun 26.
8
The obesity paradox is mostly driven by decreased noncardiovascular disease mortality in the oldest old in China: a 20-year prospective cohort study.肥胖悖论在中国最年长者中主要由非心血管疾病死亡率降低所致:一项20年前瞻性队列研究
Nat Aging. 2022 May;2(5):389-396. doi: 10.1038/s43587-022-00201-3. Epub 2022 Apr 25.
9
Associations of New-Onset Atrial Fibrillation With Risks of Cardiovascular Disease, Chronic Kidney Disease, and Mortality Among Patients With Type 2 Diabetes.新发心房颤动与 2 型糖尿病患者心血管疾病、慢性肾脏病和死亡风险的相关性。
Diabetes Care. 2022 Oct 1;45(10):2422-2429. doi: 10.2337/dc22-0717.
10
Reassessing Human Adipose Tissue.重新评估人体脂肪组织。
N Engl J Med. 2022 Feb 24;386(8):768-779. doi: 10.1056/NEJMra2032804.

人体测量代谢亚型与健康结局:一项数据驱动的聚类分析。

Anthropometric metabolic subtypes and health outcomes: A data-driven cluster analysis.

作者信息

Ding Li, Fan Yuxin, Yang Xiaoyun, Chang Lina, Wang Jiaxing, Ma Xiaohui, He Qing, Hu Gang, Liu Ming

机构信息

Department of Endocrinology and Metabolism, Tianjin Medical University General Hospital, Tianjin, China.

Chronic Disease Epidemiology Laboratory, Pennington Biomedical Research Center, Baton Rouge, Louisiana, USA.

出版信息

Diabetes Obes Metab. 2025 Jun;27(6):2955-2966. doi: 10.1111/dom.16299. Epub 2025 Feb 28.

DOI:10.1111/dom.16299
PMID:40019142
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12049265/
Abstract

AIMS

The aims of the study were to develop and validate WHOLISTIIC, a data-driven cluster analysis for identifying anthropometric metabolic subtypes.

MATERIALS AND METHODS

K-means cluster analysis was performed in 397 424 UK Biobank participants based on five domains, that is, central obesity (waist-to-height ratio), general obesity (body mass index [BMI]), limb strength (handgrip strength), insulin resistance (triglyceride to high-density lipoprotein cholesterol [HDLc] ratio) and inflammatory condition (neutrophil-to-lymphocyte ratio). Replication was done in the NHANES. Cox proportional hazards regression models were used to estimate the associations of clusters with incident adverse health outcomes.

RESULTS

Six replicable clusters were identified. Compared with individuals in cluster 1 (lowest BMI with preserved handgrip strength), individuals in cluster 2 (highest handgrip strength) were not at increased risk of all-cause mortality despite higher BMI, but had small yet significant increased risks of cardiovascular mortality, incident major adverse cardiovascular events (MACE), chronic renal failure and decreased risks of mortality due to respiratory disease, as well as incident dementia; individuals in cluster 3 (lowest handgrip strength and borderline elevated BMI), cluster 4 (highest triglyceride-to-HDLc ratio and moderately elevated BMI), cluster 5 (highest neutrophil-to-lymphocyte ratio and borderline elevated BMI) and cluster 6 (highest BMI) had substantially increased risks of all-cause, cardiovascular, and cancer mortality, incident MACE and chronic renal failure. The associations of anthropometric clusters with the risk of mortality were replicated in the NHANES cohort.

CONCLUSIONS

Anthropometric metabolic subtypes identified with easily accessible parameters reflecting multifaceted pathology of overweight and obesity were associated with distinct risks of long-term adverse health outcomes.

摘要

目的

本研究的目的是开发并验证WHOLISTIIC,这是一种用于识别体脂代谢亚型的数据驱动聚类分析方法。

材料与方法

基于五个领域,即中心性肥胖(腰高比)、全身肥胖(体重指数[BMI])、肢体力量(握力)、胰岛素抵抗(甘油三酯与高密度脂蛋白胆固醇[HDLc]的比值)和炎症状态(中性粒细胞与淋巴细胞的比值),对397424名英国生物银行参与者进行K均值聚类分析。在国家健康与营养检查调查(NHANES)中进行了重复验证。采用Cox比例风险回归模型估计聚类与不良健康结局事件之间的关联。

结果

确定了六个可重复的聚类。与聚类1(BMI最低且握力保留)中的个体相比,聚类2(握力最高)中的个体尽管BMI较高,但全因死亡率风险并未增加,但心血管死亡率、主要不良心血管事件(MACE)、慢性肾衰竭的风险有小幅但显著增加,而呼吸系统疾病导致的死亡率和痴呆症的风险则降低;聚类3(握力最低且BMI临界升高)、聚类4(甘油三酯与HDLc比值最高且BMI中度升高)、聚类5(中性粒细胞与淋巴细胞比值最高且BMI临界升高)和聚类6(BMI最高)的全因、心血管和癌症死亡率、MACE事件和慢性肾衰竭的风险大幅增加。体脂聚类与死亡率风险之间的关联在NHANES队列中得到了重复验证。

结论

通过反映超重和肥胖多方面病理的易于获取的参数确定的体脂代谢亚型与长期不良健康结局的不同风险相关。